Glioblastoma (GBM) remains a substantial obstacle in therapy since the blood-brain barrier (BBB) and tumor microenvironment (TME) severely prevent the access of most exogenous therapeutic agents to the central nervous system. Overcoming this dual defense estab... ...

请注册登录后继续浏览